medigraphic.com
SPANISH

Revista de Investigación Clínica

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Authors instructions        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2005, Number 3

Rev Invest Clin 2005; 57 (3)

¿Does cranberry juice have bacteriostatic activity?

Monroy-Torres R, Macías AE
Full text How to cite this article

Language: Spanish
References: 14
Page: 442-446
PDF size: 58.35 Kb.


Key words:

Vaccinium macrocarpon, Bacteriuria, Urinary tract infection, Bacteriostatic.

ABSTRACT

Background. Cranberry juice is used to prevent urinary infections but it is not known if it inhibits bacterial growth in urine or in bacteriologic broth. Objective. Determining if cranberry juice has bacteriostatic properties. Methods. The urine of 20 female university students was studied before and after drinking cranberry juice. Both specimens were submitted to pH determination and inoculated with a control strain of Escherichia coli. After 1 and 2 hours of incubation with the inoculum, the urine specimens were plated on agar to determine their bacterial counts. Additionally, the growth of 10 E. coli strains were studied in broths with serial dilutions of juice. Results. No inhibitory effect on bacterial growth was observed in urine after drinking cranberry juice. After 1 and two hours of incubation with the E. coli inoculum, control urine grew an average 132.2 and 153 x 103 colony-forming units/mL, respectively. After 1 and two hours of incubation with the inoculum, post-intervention urine grew an average 141.4 and 170.6 x 103 CFU/mL, respectively (p › 0.05). Against expectations, an increment was observed in urinary pH after drinking the juice (average pH in controls, 5.8 vs. 6.2 in post-intervention specimens; p = 0.043). In vitro analysis did not find a negative trend of E. coli growth in broths with higher concentrations of juice. Conclusions. Cranberry juice was not associated with bacteriostatic properties and its ingestion was not followed by a drop in urinary pH, which suggests that these are not its potential beneficial effects for the management and the prevention of urinary tract infections.


REFERENCES

  1. Raz R. Asymptomatic bacteriuria. Clinical significance and management. Int J Antimicrob Agents 2003; 22(Suppl. 2): 45-7.

  2. Ofek I, Goldhar J, Zafiri D. Anti-Escherichia coli adhesion activity of cranberry and blueberry juices (letter). N Engl J Med 1991; 324: 1599.

  3. Ahuja S, Kaack B, Roberts J. Loss of fimbrial adhesion with the addition of Vaccinum macrocarpon to the growth medium of P- fimbriated Escherichia coli. J Urol 1998; 159: 559-62.

  4. Avorn J, Monane M, Gurwitz JH, Glynn RJ, Choodnovskiy I, Lipsitz LA. Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA 1994; 271: 751-4.

  5. Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, Uhari M. Randomized trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 2001; 322: 1571-3.

  6. Foxman B, Geiger AM, Palin K, Gillespie B, Koopman JS. First-time urinary tract infection and sexual behavior. Epidemiology 1995; 6: 162-8.

  7. Lowe FC, Fagelman E. Cranberry juice and urinary tract infections: What is the evidence? Urology 2001; 57: 407-13.

  8. Sobota AE. Inhibition of bacterial adherence by cranberry juice: potential use for the treatment of urinary tract infections. J Urol 1984; 131: 1013-16.

  9. Howell AB, Vorsa N, Marderosian AD, Foo LY. Inhibition of the adherence of P- fimbriated Escherichia coli to uroephitelial cell surfaces by proanthocyanidin extracts from cranberries. N Engl J Med 1998; 339: 1085-6.

  10. Lee YL, Owens J, Thrupp L, Cesario TC. Does cranberry juice have antibacterial activity? JAMA 2000; 283: 1691.

  11. Howell AB, Foxman B. Cranberry juice and adhesion of antibiotic-resistant uropathogens. JAMA 2002; 287: 1853-4.

  12. Pocock SJ. Clinical trials. Chichester, UK: John Wiley & Sons; 1983.

  13. Sifuentes-Osornio J, Donís-Hernandez J. Considerations regarding the need for bacterial resistance networks. In: Salvatierra-Gonzalez R, Benguigui Y (Eds.). Antimicrobial resistance in the Americas: Magnitude and containment of the problem. Washington, D.C.: Pan American Health Organization; 2000, p. 8-10.

  14. Raz R, Chazan B, Dan M. Cranberry juice and tract infection. CID 2004; 38(15): 1413-19.




2020     |     www.medigraphic.com

Mi perfil

CÓMO CITAR (Vancouver)

Rev Invest Clin. 2005;57